These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 7693531

  • 21. Use of pancreatic Schilling test to determine efficiency of pancreatic enzyme delivery in pancreatic insufficiency.
    Brugge WR, Goldberg HJ, Burke CA, Depping BJ.
    Dig Dis Sci; 1988 Oct; 33(10):1226-32. PubMed ID: 3168695
    [Abstract] [Full Text] [Related]

  • 22. Pancreatic enzyme therapy.
    Mössner J, Keim V.
    Dtsch Arztebl Int; 2010 Aug; 108(34-35):578-82. PubMed ID: 21904592
    [Abstract] [Full Text] [Related]

  • 23. A modified ¹³C-mixed triglyceride breath test detects moderate pancreatic exocrine insufficiency.
    Keller J, Brückel S, Jahr C, Layer P.
    Pancreas; 2011 Nov; 40(8):1201-5. PubMed ID: 21705945
    [Abstract] [Full Text] [Related]

  • 24. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M, Meuris S, Gohimont AC, Buedts K, Cremer M.
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [Abstract] [Full Text] [Related]

  • 25. The Role of Sphere Size in the Context of Pancreatin Therapy for Exocrine Pancreatic Insufficiency: A Systematic Review.
    Petersen KU, Malfertheiner P, Mössner J.
    J Gastrointestin Liver Dis; 2021 Mar 12; 30(1):132-141. PubMed ID: 33548122
    [Abstract] [Full Text] [Related]

  • 26. [PANCREATIC EXOCRINE INSUFFICIENCY AND ITS CORRECTION IN CHILDREN WITH TYPE I DIABETES IN COMBINATION WITH CELIAC DISEASE].
    Bolshova EV, Lukashuk IV, Lukashuk VD.
    Lik Sprava; 2015 Mar 12; (1-2):167-9. PubMed ID: 26118067
    [Abstract] [Full Text] [Related]

  • 27. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?
    Domínguez-Muñoz JE.
    Adv Med Sci; 2011 Mar 12; 56(1):1-5. PubMed ID: 21450558
    [Abstract] [Full Text] [Related]

  • 28. Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency.
    Abrams CK, Hamosh M, Dutta SK, Hubbard VS, Hamosh P.
    Gastroenterology; 1987 Jan 12; 92(1):125-9. PubMed ID: 3781179
    [Abstract] [Full Text] [Related]

  • 29. Replacement therapy in pancreatic insufficiency with a new pancreatin preparation respecting the physiological ratio of lipase/trypsin activity.
    Pap A, Varró V.
    Hepatogastroenterology; 1988 Apr 12; 35(2):83-6. PubMed ID: 3371850
    [Abstract] [Full Text] [Related]

  • 30. 13C labelled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency.
    Ventrucci M, Cipolla A, Ubalducci GM, Roda A, Roda E.
    Gut; 1998 Jan 12; 42(1):81-7. PubMed ID: 9505890
    [Abstract] [Full Text] [Related]

  • 31. [Measurement of fecal elastase 1 by immunoreactivity: a new indirect test of the pancreatic function].
    Stein J, Schoonbroodt D, Jung M, Lembcke B, Caspary WF.
    Gastroenterol Clin Biol; 1996 Jan 12; 20(5):424-9. PubMed ID: 8761139
    [Abstract] [Full Text] [Related]

  • 32. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations.
    Kraisinger M, Hochhaus G, Stecenko A, Bowser E, Hendeles L.
    J Clin Pharmacol; 1994 Feb 12; 34(2):158-66. PubMed ID: 8163716
    [Abstract] [Full Text] [Related]

  • 33. Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease.
    Layer P, Keller J.
    J Clin Gastroenterol; 1999 Jan 12; 28(1):3-10. PubMed ID: 9916657
    [Abstract] [Full Text] [Related]

  • 34. Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs.
    Griffin SM, Alderson D, Farndon JR.
    Gut; 1989 Jul 12; 30(7):1012-5. PubMed ID: 2759481
    [Abstract] [Full Text] [Related]

  • 35. Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis.
    Bruno MJ, Borm JJ, Hoek FJ, Delzenne B, Hofmann AF, de Goeij JJ, van Royen EA, van Leeuwen DJ, Tytgat GN.
    Dig Dis Sci; 1998 Jan 12; 43(1):203-13. PubMed ID: 9508526
    [Abstract] [Full Text] [Related]

  • 36. Treatment of pancreatic exocrine deficiency.
    Sarner M.
    World J Surg; 2003 Nov 12; 27(11):1192-5. PubMed ID: 14534818
    [Abstract] [Full Text] [Related]

  • 37. Exocrine pancreatic insufficiency-like syndrome in giraffe.
    Lechowski R, Pisarski J, Gosławski J, Lenarcik M.
    J Wildl Dis; 1991 Oct 12; 27(4):728-30. PubMed ID: 1721936
    [Abstract] [Full Text] [Related]

  • 38. Controversies in the treatment of exocrine pancreatic insufficiency.
    DiMagno EP.
    Dig Dis Sci; 1982 Jun 12; 27(6):481-4. PubMed ID: 6919479
    [No Abstract] [Full Text] [Related]

  • 39. Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS.
    Maev IV, Kucheryavyy YA, Gubergrits NB, Bonnacker I, Shelest EA, Janssen-van Solingen GP, Domínguez-Muñoz JE.
    Drugs R D; 2020 Dec 12; 20(4):369-376. PubMed ID: 33211277
    [Abstract] [Full Text] [Related]

  • 40. Monitoring the effect of substitution therapy in patients with exocrine pancreatic insufficiency.
    Jørgensen BB, Pedersen NT, Worning H.
    Scand J Gastroenterol; 1991 Mar 12; 26(3):321-6. PubMed ID: 1853155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.